Image from Google Jackets

Targeted radionuclide therapy / editor, Tod W. Speer

Contributor(s): Speer, Tod W., editor literario
Material type: materialTypeLabelE-bookPublisher: Philadelphia : Lippincott Williams & Wilkins, 2011Description: 1 recurso en línea (XVII, 537 páginas) : ilustraciones.ISBN: 9780781796934; 0781796938.Subject: Cáncer -- Radioterapia | Isótopos radiactivosOnline resources: Acceso a este recurso digital (usuarios Universidad Europea de Madrid)Digital Resources Summary: "Radioimmunotherapy, also known as systemic targeted radiation therapy, uses antibodies, antibody fragments, or compounds as carriers to guide radiation to the targets. It is a topic rapidly increasing in importance and success in treatment of cancer patients. This book represents a comprehensive amalgamation of the radiation physics, chemistry, radiobiology, tumor models, and clinical data for targeted radionuclide therapy. It outlines the current challenges and provides a glimpse at future directions. With significant advances in cell biology and molecular engineering, many targeting constructs are now available that will safely deliver these highly cytotoxic radionuclides in a targeted fashion"--Provided by publisher.
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Collection Call number Status Date due Barcode Item holds
LIBRO-E NO PRÉSTAMO LIBRO-E NO PRÉSTAMO Madrid Digital Acceso Electrónico (UEM) Ciencias de la Salud RC271 .R26 2011 EB (Browse shelf(Opens below)) Acceso electrónico eBook121657
Total holds: 0

Incluye referencias bibliográficas e índice

"Radioimmunotherapy, also known as systemic targeted radiation therapy, uses antibodies, antibody fragments, or compounds as carriers to guide radiation to the targets. It is a topic rapidly increasing in importance and success in treatment of cancer patients. This book represents a comprehensive amalgamation of the radiation physics, chemistry, radiobiology, tumor models, and clinical data for targeted radionuclide therapy. It outlines the current challenges and provides a glimpse at future directions. With significant advances in cell biology and molecular engineering, many targeting constructs are now available that will safely deliver these highly cytotoxic radionuclides in a targeted fashion"--Provided by publisher.

There are no comments on this title.

to post a comment.
Share